Progyny (PGNY) Stock Forecast & Price Target

Compare

668 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PGNY Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Progyny

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PGNY Stock 12 Month Forecast

Average Price Target

$29.89

▲(25.22% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Progyny in the last 3 months. The average price target is $29.89 with a high forecast of $35.00 and a low forecast of $26.00. The average price target represents a 25.22% change from the last price of $23.87.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","21":"$21","26":"$26","31":"$31","36":"$36"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.89,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$29.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$26.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,21,26,31,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.68,26.396923076923077,27.113846153846154,27.83076923076923,28.54769230769231,29.264615384615386,29.981538461538463,30.698461538461537,31.415384615384617,32.13230769230769,32.84923076923077,33.566153846153846,34.28307692307692,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.68,26.003846153846155,26.327692307692306,26.65153846153846,26.975384615384616,27.299230769230768,27.623076923076923,27.946923076923078,28.270769230769233,28.594615384615384,28.91846153846154,29.24230769230769,29.566153846153846,{"y":29.89,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.68,25.704615384615384,25.729230769230767,25.753846153846155,25.77846153846154,25.803076923076922,25.827692307692306,25.852307692307694,25.876923076923077,25.90153846153846,25.926153846153845,25.950769230769232,25.975384615384616,{"y":26,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.17,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.53,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.06,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.49,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.22,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.71,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.27,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.68,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$35.00

Average Price Target$29.89

Lowest Price Target$26.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Larsen

BTIG

$30→$35

Buy

46.63%

Upside

Reiterated

01/21/26

Progyny price target raised to $35 from $30 at BTIGProgyny price target raised to $35 from $30 at BTIG

Constantine Davides

Citizens JMP

$30

Buy

25.68%

Upside

Upgraded

01/20/26

Progyny upgraded to Outperform from Market Perform at CitizensProgyny upgraded to Outperform from Market Perform at Citizens

Allen Lutz

Bank of America Securities

$30

Buy

25.68%

Upside

Reiterated

01/16/26

Analysts Are Bullish on These Healthcare Stocks: Progyny (PGNY), Ionis Pharmaceuticals (IONS)

Jailendra Singh

Truist Financial

Buy

―

Reiterated

01/13/26

Analysts Are Bullish on Top Healthcare Stocks: Gilead Sciences (GILD), Progyny (PGNY)

Scott Schoenhaus

KeyBanc

$30→$32

Buy

34.06%

Upside

Reiterated

01/08/26

KeyBanc Remains a Buy on Progyny (PGNY)

Peter Warendorf

Barclays

$29

Buy

21.49%

Upside

Initiated

12/08/25

Progyny initiated with an Overweight at BarclaysProgyny initiated with an Overweight at Barclays

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$33

Buy

38.25%

Upside

Reiterated

11/19/25

Progyny (PGNY) Receives a Buy from Jefferies

Richard Close

Canaccord Genuity

$23→$26

Hold

8.92%

Upside

Reiterated

11/17/25

Progyny price target raised to $26 from $23 at CanaccordProgyny price target raised to $26 from $23 at Canaccord

Lisa Gill

J.P. Morgan

$25→$26

Hold

8.92%

Upside

Reiterated

11/11/25

Progyny price target raised to $26 from $25 at JPMorganProgyny price target raised to $26 from $25 at JPMorgan

Sarah James

Cantor Fitzgerald

$28

Buy

17.30%

Upside

Reiterated

11/06/25

Progyny (PGNY) Gets a Buy from Cantor Fitzgerald

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/01/25

Our meeting confirmed what remains our view of a highly positive risk‐reward skew, and we reiterate our Outperform rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Larsen

BTIG

$30→$35

Buy

46.63%

Upside

Reiterated

01/21/26

Progyny price target raised to $35 from $30 at BTIGProgyny price target raised to $35 from $30 at BTIG

Constantine Davides

Citizens JMP

$30

Buy

25.68%

Upside

Upgraded

01/20/26

Progyny upgraded to Outperform from Market Perform at CitizensProgyny upgraded to Outperform from Market Perform at Citizens

Allen Lutz

Bank of America Securities

$30

Buy

25.68%

Upside

Reiterated

01/16/26

Analysts Are Bullish on These Healthcare Stocks: Progyny (PGNY), Ionis Pharmaceuticals (IONS)

Jailendra Singh

Truist Financial

Buy

―

Reiterated

01/13/26

Analysts Are Bullish on Top Healthcare Stocks: Gilead Sciences (GILD), Progyny (PGNY)

Scott Schoenhaus

KeyBanc

$30→$32

Buy

34.06%

Upside

Reiterated

01/08/26

KeyBanc Remains a Buy on Progyny (PGNY)

Peter Warendorf

Barclays

$29

Buy

21.49%

Upside

Initiated

12/08/25

Progyny initiated with an Overweight at BarclaysProgyny initiated with an Overweight at Barclays

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$33

Buy

38.25%

Upside

Reiterated

11/19/25

Progyny (PGNY) Receives a Buy from Jefferies

Richard Close

Canaccord Genuity

$23→$26

Hold

8.92%

Upside

Reiterated

11/17/25

Progyny price target raised to $26 from $23 at CanaccordProgyny price target raised to $26 from $23 at Canaccord

Lisa Gill

J.P. Morgan

$25→$26

Hold

8.92%

Upside

Reiterated

11/11/25

Progyny price target raised to $26 from $25 at JPMorganProgyny price target raised to $26 from $25 at JPMorgan

Sarah James

Cantor Fitzgerald

$28

Buy

17.30%

Upside

Reiterated

11/06/25

Progyny (PGNY) Gets a Buy from Cantor Fitzgerald

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/01/25

Our meeting confirmed what remains our view of a highly positive risk‐reward skew, and we reiterate our Outperform rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Progyny

3 Months

xxx

Success Rate

4/7 ratings generated profit

Average Return

-1.63%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of -1.63% per trade.

1 Year

Sarah JamesCantor Fitzgerald

Success Rate

9/12 ratings generated profit

Average Return

+31.23%

reiterated a buy rating 3 months ago

Copying Sarah James's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +31.23% per trade.

2 Years

xxx

Success Rate

12/15 ratings generated profit

Average Return

+23.81%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +23.81% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PGNY Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PGNY has received 30 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. PGNY average Analyst price target in the past 3 months is 29.89.

Each month's total comprises the sum of three months' worth of ratings.

PGNY Financial Forecast

PGNY Earnings Forecast

Next quarter’s earnings estimate for PGNY is $0.15 with a range of $0.12 to $0.18. The previous quarter’s EPS was $0.15. PGNY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year PGNY has Performed in-line its overall industry.

PGNY Sales Forecast

Next quarter’s sales forecast for PGNY is $307.46M with a range of $295.87M to $326.32M. The previous quarter’s sales results were $313.35M. PGNY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year PGNY has Performed in-line its overall industry.

PGNY Stock Forecast FAQ

What is PGNY’s average 12-month price target, according to analysts?

Based on analyst ratings, Progyny’s 12-month average price target is 29.89.

What is PGNY’s upside potential, based on the analysts’ average price target?

Progyny has 25.22% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PGNY a Buy, Sell or Hold?

Progyny has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Progyny’s price target?

The average price target for Progyny is 29.89. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $26.00. The average price target represents 25.22% Increase from the current price of $23.87.

What do analysts say about Progyny?

Progyny’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of PGNY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Progyny (PGNY) Stock Forecast & Price Target

PGNY Analyst Ratings

PGNY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Progyny

PGNY Analyst Recommendation Trends

PGNY Financial Forecast

PGNY Earnings Forecast

PGNY Sales Forecast

PGNY Stock Forecast FAQ

Detailed List of Analyst Forecasts